The Royal Berkshire Hospital has joined the world’s largest clinical trial of drug therapy for patients with Covid-19 – the RECOVERY Study.
Patients with suspected or proven Covid-19 who are admitted to the hospital will be offered the chance to participate in the research, which is taking place at hospitals across the UK and currently has 6,000 patients recruited from 169 different sites. The RBH has 41 patients involved at the moment.
The findings will help determine the most effective ways of treating Covid-19 with medications that are already available and in use for other conditions.
Dr Andrew Walden, Intensive Care consultant and co-Principal Investigator for the study said:
'This is a National Institute for Health Research mandated study and we are privileged at the RBH to have an excellent team of Research Nurses, Assistants and Doctors who are committed to allowing as many patients as possible the opportunity to partake in this vital trial. It is established in ICU and the Respiratory wards and we have rolled it out more widely in the last few days”.